蛋白質治療市場：分析與預測 (2022-2028)

從 2022 年到 2028 年，全球蛋白質療法市場規模預計將以約 6.3% 的複合年增長率增長。

使用治療性蛋白質製造疫苗以預防自身免疫性疾病、外來病原體和癌症，預計將推動該市場的增長。 此外，蛋白質組學研究的增長預計將推動市場，增加有可能顯著改善人類健康的新蛋白質藥物的出現。

本報告調查了全球蛋白質治療市場，定義和概述了市場，分析了影響市場增長、變化和市場規模預測的各種因素，總結了細分、法律和監管環境、供需趨勢、競爭環境，主要公司簡介等

內容

第一章介紹

第二章調查方法及前提條件

第 3 章市場概述

第 4 章執行摘要

第 5 章 COVID-19：對蛋白質治療市場的影響

第 6 章蛋白質治療市場：收益趨勢和預測

第 7 章市場洞察：按類型

• 單克隆抗體
• 胰島素
• 融合蛋白
• 促紅細胞生成素
• 干擾素
• 其他

第 8 章市場洞察：按應用

• 癌症
• 代謝紊亂
• 免疫疾病
• 血液病
• 其他

第 9 章市場洞察：按蛋白質功能分類

• □/調節活性
• 特殊定位活動
• 疫苗
• 其他

第 10 章市場洞察：最終用戶

• 醫院和診所
• 專科中心
• 其他

第 11 章市場洞察：按地區

• 北美
• 歐洲
• 亞太地區
• 其他地區

第 12 章蛋白質治療市場：市場動態

• 市場驅動力
• 市場問題
• 影響分析

第 13 章蛋白質治療市場：市場機會

第 14 章蛋白質治療市場::市場趨勢

第 15 章政策和監管框架

第16章需求側與供給側分析

• 需求方分析
• 供應方分析

第 17 章價值鏈分析

第 18 章衝突場景

第十九章公司簡介

• Abbott Laboratories
• Amgen Inc.
• Baxter International Inc.
• Eli Lilly And Company
• F. Hoffmann La Roche Ltd
• Johnson and Johnson
• Merck and Co., Inc.
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi

第20章 免責事項

Global protein therapeutics market is expected to register a CAGR of around ~6.3% over the period of 2022-2028. This is mainly due to the use of therapeutic proteins for manufacturing vaccines as they provide defense against autoimmune diseases, foreign agents, and cancer is likely to promote the market. Also, Protein therapeutics have stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make protein therapeutics products more sustainable with fewer side effects and cost-effective. Major pharmaceutical companies are investing heavily in their products due to the rising prevalence of chronic diseases, and the growing geriatric population. According to Union for International Cancer Control (UICC), the world's population is aging rapidly, with 703 million people worldwide above the age of 65 years, representing 9.1% of the global population. Furthermore, Population aging will have consequences for cancer control globally as cancer is more prevalent in older adults. In addition, protein therapy is similar to gene therapy, which involves protein delivery in specific amounts to the body to facilitate the precise functioning of different glands and other organs in the body. Moreover, growth in proteomic research is expected to lead to an increase in the emergence of new protein drugs and drugs that have the potential to significantly improve human health which drives the market. Therefore, the market for protein therapeutics is expected to witness significant growth during the forecast period.

Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann La Roche Ltd, Johnson and Johnson, Merck and Co., Inc., Novo Nordisk AS, Pfizer Inc., Sanofi are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst application, metabolic disorders are expected to witness significant CAGR during the forecast period"

Based on application, the market is categorized into cancer, metabolic disorders, immunologic disorders, hematological disorders, and others. Among these, metabolic disorders are expected to witness a significant CAGR during the forecast period. This is mainly due to the requirement for quality drugs and versatile therapies for disease treatment, especially coronary heart disease, diabetes, and stroke which is expected to boost the growth of this segment. According to the American Heart Association, 47 million Americans have it. That's almost a staggering 1 out of every 6 people in 2021. Therefore, this segment rising due to the use of protein therapeutics in the global market is likely to boost the demand for protein therapeutics.

"Amongst protein function, enzymatic and regulatory activity category accounted for the significant share in the market in 2020"

Based on protein function, the market is classified into enzymatic and regulatory activity, special targeting activity, vaccines, and others. Amongst protein functions, the enzymatic and regulatory activity category accounted for a significant share of the market. Based on their pharmacological activity, they can be divided into five groups: (a) replacing a protein that is deficient or abnormal; (b) augmenting an existing pathway; (c) providing a novel function or activity; (d) interfering with a molecule or organism; and (e) delivering other compounds or proteins, such as a radionuclide, cytotoxic drug, or effector protein.

"Amongst end-user, hospitals and clinics category accounted for the significant share in the market in 2020"

Based on end-user, the market is categorized into hospitals and clinics, specialty centers, and others. Among these, hospitals and clinics are expected to witness the highest CAGR during the forecast period. The hospitals and clinics are estimated to add to the growing need for protein therapeutics products which is expected to drive the growth of this segment. Also, the use of therapeutic proteins for manufacturing vaccines as they provide defense against autoimmune diseases, foreign agents, and cancer is likely to promote the market. For instance, In June 2022, Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

"North America to witness significant growth during the forecast period"

North America is expected to show the highest CAGR growth in the protein therapeutics market. The major contributors to the growth of this market are US and Canada. This is mainly due to the growing various protein therapeutics and highly developed economy, high product adoption rates, awareness about protein-based therapeutics, and surge in strategic developments among key players of the market in the U.S. economy. For instance, In July 2020, Kymera Therapeutics Inc. announced the company has entered into a multi-program strategic collaboration with Sanofi (NASDAQ: SNY) to develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases. Moreover, the development of advanced protein therapeutics by major companies and the diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global protein therapeutics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Protein Therapeutics Market
• 2.2. Research Methodology of the Protein Therapeutics Market
• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PROTEIN THERAPEUTICS MARKET COVID-19 IMPACT

6 GLOBAL PROTEIN THERAPEUTICS MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

• 7.1. Monoclonal Antibodies
• 7.2. Insulin
• 7.3. Fusion Protein
• 7.4. Erythropoietin
• 7.5. Interferon
• 7.6. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Cancer
• 8.2. Metabolic Disorders
• 8.3. Immunologic Disorders
• 8.4. Hematological Disorders
• 8.5. Others

9 MARKET INSIGHTS BY PROTEIN FUNCTION

• 9.1. Enzymatic and Regulatory Activity
• 9.2. Special Targeting Activity
• 9.3. Vaccines
• 9.4. Others

10 MARKET INSIGHTS BY END-USER

• 10.1. Hospitals and Clinics
• 10.2. Specialty Centers
• 10.3. Others

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. U.S.
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. UK
  • 11.2.3. France
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia-Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Australia
  • 11.3.5. Rest of Asia-Pacific
• 11.4. Rest of World

12 PROTEIN THERAPEUTICS MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 PROTEIN THERAPEUTICS MARKET OPPORTUNITIES

14 PROTEIN THERAPEUTICS MARKET TRENDS

15 POLICY & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY-SIDE ANALYSIS

• 16.1. Demand Side Analysis
• 16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porter's Five Forces Analysis

19 COMPANY PROFILED

• 19.1. Abbott Laboratories
• 19.2. Amgen Inc.
• 19.3. Baxter International Inc.
• 19.4. Eli Lilly And Company
• 19.5. F. Hoffmann La Roche Ltd
• 19.6. Johnson and Johnson
• 19.7. Merck and Co., Inc.
• 19.8. Novo Nordisk AS
• 19.9. Pfizer Inc.
• 19.10. Sanofi

20 DISCLAIMER